K2 PRINCIPAL FUND, L.P. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 23 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
K2 PRINCIPAL FUND, L.P. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$9,332,000
-1.2%
9,0000.0%0.80%
+28.6%
Q4 2021$9,445,000
-3.7%
9,0000.0%0.63%
-21.4%
Q3 2021$9,804,000
-1.5%
9,0000.0%0.80%
-3.7%
Q2 2021$9,953,000
+361.4%
9,000
+350.0%
0.83%
+386.5%
Q1 2021$2,157,0002,0000.17%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Opti Capital Management, LP 11,901$11,946,0002.07%
Context Capital Management, LLC 1,000,000$997,0000.56%
WOLVERINE ASSET MANAGEMENT LLC 33,392,000$33,442,0000.42%
SSI INVESTMENT MANAGEMENT LLC 3,000,000$2,991,0000.22%
CSS LLC/IL 2,876,000$2,883,0000.18%
PALISADE CAPITAL MANAGEMENT, LP 5,000,000$5,016,0000.15%
HBK INVESTMENTS L P 10,116,000$10,186,0000.13%
TENOR CAPITAL MANAGEMENT Co., L.P. 1,817,000$1,835,0000.11%
LINDEN ADVISORS LP 6,269,000$6,290,0000.08%
LAZARD ASSET MANAGEMENT LLC 15,000,000$15,028,0000.02%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders